Home/Rhine Pharma/Jonathan Barlow
JB

Jonathan Barlow

Senior Advisor

Rhine Pharma

Therapeutic Areas

Rhine Pharma Pipeline

DrugIndicationPhase
RHN001-Dx (⁹⁹ᵐTc-PSMA)PSMA-positive prostate cancer (imaging)Phase 1
RHN001-Tx (¹⁸⁸Re-PSMA)PSMA-positive prostate cancer (therapy)Phase 1/2a